REL Share Price Performance
UK£25.25
-12.58 (-33.25%)
32.6% undervalued intrinsic discount
UK£37.46
Fair Value
Price UK£25.25
AnalystConsensusTarget UK£37.46
Aadi UK£22.13
AnalystHighTarget UK£52.33
Fair ValueUK£37.46
Share Pricen/a
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 102 Fair Values set on narratives written by author
REL Community Narratives
AN
Fair Value UK£37.46 32.6% undervalued intrinsic discount
Analysts Highlight Mixed Outlook for RELX as Valuation and Profit Estimates Rise
2users have liked this narrative
0users have commented on this narrative
54users have followed this narrative
AA
Aadi·
Fair Value UK£22.13 14.1% overvalued intrinsic discount
Be sceptical about AI Hype - RELX is an undervalued goldmine of data
1users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value UK£52.33 51.8% undervalued intrinsic discount
AI Analytics And Data Rich Risk Tools Will Transform Long Term Prospects
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Be sceptical about AI Hype - RELX is an undervalued goldmine of data
The Business And Their Model RELX is a highly profitable DaaS (Data-as-a-Service) analytics company. They use their proprietary datasets to sell subscription based tools to industries spanning scientific research, medicine, law, and banking.Read more
63
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Analysts Highlight Mixed Outlook for RELX as Valuation and Profit Estimates Rise
Key Takeaways Accelerated shift to AI-powered digital products and data analytics is deepening customer value, spurring recurring revenue growth, and expanding profit margins. Focus on high-value digital subscriptions and prudent capital allocation strengthens long-term revenue momentum and supports sustainable EPS expansion.Read more
801
users have viewed this narrative2users have liked this narrative
0users have commented on this narrative
54users have followed this narrative
AN
UK£37.46
32.6% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
6.63% p.a.
Profit Margin
23.34%
Future PE
30.78x
Price in 2029
UK£46.88
AI Analytics And Data Rich Risk Tools Will Transform Long Term Prospects
Catalysts About RELX RELX provides information based analytics and decision tools across risk, scientific, technical and medical, legal and exhibitions markets. What are the underlying business or industry changes driving this perspective?Read more
93
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
UK£52.33
51.8% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
8.16% p.a.
Profit Margin
24.03%
Future PE
39.82x
Price in 2029
UK£65.53
Trending Discussion
Recently Updated Narratives
AA
Be sceptical about AI Hype - RELX is an undervalued goldmine of data
Fair Value: UK£22.13 14.1% overvalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
REL: AI Execution Risk Repricing Will Support Future Multiple Re Rating Potential
Fair Value: UK£37.46 32.6% undervalued intrinsic discount
54 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AI Analytics And Data Rich Risk Tools Will Transform Long Term Prospects
Fair Value: UK£52.33 51.8% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
RELX PLC Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Jul 23, 2026
- 1.15
- 66.29%
- 21.53%
- 300.0%
About REL
- Founded
- 1903
- Employees
- 36660
- CEO
- WebsiteView website
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
